ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
225.95
-0.03 (-0.01%)
Oct 8, 2026, 2:14 PM EDT - Market open
ResMed Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $235 | Hold | Maintains | $235 | +4.01% | Oct 2, 2026 |
| RBC Capital | RBC Capital | Buy Upgrades $244 → $262 | Buy | Upgrades | $244 → $262 | +15.95% | Sep 15, 2026 |
| Citi | Citi | Hold Maintains $235 → $240 | Hold | Maintains | $235 → $240 | +6.22% | Sep 10, 2026 |
| KeyBanc | KeyBanc | Buy Reiterates $255 → $267 | Buy | Reiterates | $255 → $267 | +18.17% | Aug 31, 2026 |
| Rothschild & Co Redburn No rating | Rothschild & Co Redburn | Hold Initiates $230 | Hold | Initiates | $230 | +1.79% | Aug 19, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $220 → $235 | Buy | Maintains | $220 → $235 | +4.01% | Aug 12, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 8, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $225 | Hold | Maintains | $225 | -0.42% | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.